Bottom line
JAFKX vs SCHLX: the short answer
JAFKX (Health Sciences Trust) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.
But JAFKX is far broader, holding 173 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
SCHLX is cheaper at 1.06% vs 1.24% — a difference of $18 a year per $10,000 invested.
Updated Nov 19, 2026
JAFKX vs SCHLX side by side
| JAFKX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | John Hancock | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.24% | 1.06% |
| Annual cost per $10k | $124 | $106 |
| 10-yr cost on $10k (prospectus) | $1,510 | $1,294 |
| Max front load | — | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +19.2% | — |
| 5-yr return (annualized) | +3.9% | — |
| 10-yr return (annualized) | +8.5% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $251.3M | $231.8M |
| Number of holdings | 173 | 65 |
| Portfolio turnover | 68% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
15 of JAFKX's top 25 holdings also appear in SCHLX's top 25.
| Holding | JAFKX | SCHLX |
|---|---|---|
| Eli Lilly and Company | 14.30% | 13.85% |
| Johnson and Johnson | 6.33% | 6.19% |
| UnitedHealth Group Incorporated | 5.95% | 5.73% |
| AbbVie Inc. | 5.28% | 4.90% |
| Merck and Co. Inc. | 4.21% | 4.85% |
| Gilead Sciences Inc. | 2.95% | 2.78% |
| Thermo Fisher Scientific Inc. | 2.67% | 3.46% |
| Vertex Pharmaceuticals Incorporated | 2.38% | 2.45% |
| Bristol-Myers Squibb Company | 2.22% | 1.50% |
| Abbott Laboratories | 2.00% | 2.39% |
| Intuitive Surgical Inc. | 1.98% | 2.69% |
| Amgen Inc. | 1.90% | 2.88% |
| Stryker Corporation | 1.87% | 2.61% |
| Danaher Corporation | 1.51% | 2.13% |
| Cardinal Health Inc. | 1.09% | 1.34% |
Source: SEC Form N-PORT
JAFKX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between JAFKX and SCHLX?
JAFKX (Health Sciences Trust) and SCHLX (DWS Health and Wellness Fund) are both mutual funds. But JAFKX is far broader, holding 173 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
Which is cheaper, JAFKX or SCHLX?
SCHLX has the lower expense ratio (1.06%).
Should I own both JAFKX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.